Effectiveness Analysis of Ultrasound-guided Intratissue Percutaneous Electrolysis (EPI) in Patient With Chronic Low Back Pain
Launched by UNIVERSIDAD DE ALMERIA · Feb 27, 2020
Trial Information
Current as of June 27, 2025
Completed
Keywords
ClinConnect Summary
Given that recently the effectiveness of intratissue percutaneous electrolysis (EPI) has become of interest in the treatment of chronic musculoskeletal pain, when conventional physiotherapy management is not successful, the EPI can promote the healing biological processes. Several studies have demonstrated that inflammation can play an important role in the progression of muscle degeneration, in addition to potentially contributing to painful symptoms in individuals with chronic low back pain.
This technique involves nonthermal, electrochemical ablation of the lesion via the use of a catho...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Low back pain ≥ 3 months.
- • Age between 30 and 67 years old.
- • Score ≥ 4 points on the Roland Morris Disability Questionnaire.
- • Not being receiving other physical therapy.
- Exclusion Criteria:
- • Presence of lumbar stenosis.
- • Diagnosis of spondylolisthesis.
- • Diagnosis of fibromyalgia.
- • Treatment with corticosteroids or oral medication in recent weeks.
- • History of spine surgery.
- • Contraindication of analgesic electrical therapy.
- • Have previously received a treatment of intratissue percutaneous electrolysis.
- • Central or peripheral nervous system disease.
About Universidad De Almeria
The Universidad de Almería is a prominent academic institution in Spain, dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, the university leverages its expertise and resources to facilitate innovative research endeavors aimed at improving patient care and outcomes. With a commitment to ethical standards and rigorous scientific methodology, the Universidad de Almería collaborates with healthcare professionals and researchers to conduct clinical trials that contribute to the development of new therapeutic interventions and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Almería, Almeria, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials